176 related articles for article (PubMed ID: 38828018)
1.
Liang R; Li P; Yang N; Xiao X; Gong J; Zhang X; Bai Y; Chen Y; Xie Z; Liao Q
Drug Des Devel Ther; 2024; 18():1833-1853. PubMed ID: 38828018
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
[TBL] [Abstract][Full Text] [Related]
3. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
4. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy.
Ren C; Li Y; Cong Z; Li Z; Xie L; Wu S
Front Immunol; 2023; 14():1129771. PubMed ID: 36999028
[TBL] [Abstract][Full Text] [Related]
5. Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8
Won S; Lee C; Bae S; Lee J; Choi D; Kim MG; Song S; Lee J; Kim E; Shin H; Basukala A; Lee TR; Lee DS; Gho YS
J Extracell Vesicles; 2023 Aug; 12(8):e12357. PubMed ID: 37563797
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
[TBL] [Abstract][Full Text] [Related]
7. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
[TBL] [Abstract][Full Text] [Related]
8. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic chemotherapy in two mouse colon cancer models.
Taniura T; Iida Y; Kotani H; Ishitobi K; Tajima Y; Harada M
Cancer Sci; 2020 Oct; 111(10):3527-3539. PubMed ID: 32816355
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane vesicles produced by
Kim SY; Kim MH; Son JH; Kim SI; Yun SH; Kim K; Kim S; Shin M; Lee JC
Virulence; 2020 Dec; 11(1):995-1005. PubMed ID: 32799627
[TBL] [Abstract][Full Text] [Related]
13. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response.
Kim OY; Park HT; Dinh NTH; Choi SJ; Lee J; Kim JH; Lee SW; Gho YS
Nat Commun; 2017 Sep; 8(1):626. PubMed ID: 28931823
[TBL] [Abstract][Full Text] [Related]
14. An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response.
Dong H; Liu S; Zhang X; Chen S; Kang L; Chen Y; Ma S; Fu X; Liu Y; Zhang H; Zou B
Cancer Res; 2019 Nov; 79(21):5587-5596. PubMed ID: 31395608
[TBL] [Abstract][Full Text] [Related]
15. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer.
Shi J; Ma Z; Pan H; Liu Y; Chu Y; Wang J; Chen L
J Microencapsul; 2020 Nov; 37(7):481-491. PubMed ID: 32700606
[TBL] [Abstract][Full Text] [Related]
16. Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice.
Gou HF; Huang J; Shi HS; Chen XC; Wang YS
PLoS One; 2014; 9(1):e85789. PubMed ID: 24465710
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic activity of Salmonella Typhimurium outer membrane nanovesicles.
Aly RG; El-Enbaawy MI; Abd El-Rahman SS; Ata NS
Exp Cell Res; 2021 Feb; 399(1):112423. PubMed ID: 33338480
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous inoculation position affects the immune environment in CT26 carcinomas.
Fu X; Yang Y; Xie J; Pan X; Yang X; Du Z; Hao E
Biochem Biophys Res Commun; 2019 Apr; 512(2):244-249. PubMed ID: 30879760
[TBL] [Abstract][Full Text] [Related]
19. Endogenous IL-33 exerts CD8
Xia Y; Ohno T; Nishii N; Bhingare A; Tachinami H; Kashima Y; Nagai S; Saito H; Nakae S; Azuma M
Biochem Biophys Res Commun; 2019 Oct; 518(2):331-336. PubMed ID: 31421832
[TBL] [Abstract][Full Text] [Related]
20. Targeting KDM4C enhances CD8
Jie X; Chen Y; Zhao Y; Yang X; Xu Y; Wang J; Meng R; Zhang S; Dong X; Zhang T; Yang K; Xu S; Wu G
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
